PW Medtech Group Limited
Research PW Medtech Group Limited (1358.HK) on Bullrun: market cap HKD 1.29B, P/E 30.2, dividend yield 7.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1358.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyHKD
- Market capHKD 1.29B
- P/E30.2
- Dividend yield7.1%
- Financial periodFY2025
- RevenueCNY 823.51M
- Revenue growth7.1%
- Net incomeCNY 94.37M
- Free cash flowCNY 135.65M
- Gross margin49.5%
Valuation Snapshot
latest market cap is HKD 1.29B; P/E is 30.2; dividend yield is 7.1%.
Peer valuation comparison
Latest P/E is 30.17x versus a Healthcare sector median of 21.69x (39.1% above).
Latest dividend yield is 7.07% versus a Healthcare sector median of 2.41% (193.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 823.51M | CNY 94.37M | CNY 135.65M | 49.5% | 0.06 | CNY 1.80B | CNY 22.00M | CNY 3.95B |
| FY2024 | CNY 768.90M | CNY 150.78M | CNY 246.34M | 54.6% | 0.1 | CNY 1.68B | CNY 12.07M | CNY 3.97B |
| FY2023 | CNY 675.08M | CNY 153.18M | CNY 129.12M | 56.4% | 0.1 | CNY 1.59B | CNY 1.13M | CNY 4.04B |
| FY2022 | CNY 536.83M | CNY 106.04M | CNY 207.38M | 55.7% | 0.07 | CNY 1.38B | CNY 4.24M | CNY 3.95B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.29B | 30.2 | 2.4% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 HKD, yield 7.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.1 CNY |
| FY2024 | 0.09 CNY |
| FY2023 | 0.05 CNY |
About PW Medtech Group Limited
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PW Medtech Group Limited's market cap?
PW Medtech Group Limited's market capitalization is HKD 1.29B.
What is PW Medtech Group Limited's P/E ratio?
PW Medtech Group Limited's price-to-earnings (P/E) ratio is 30.2.
Does PW Medtech Group Limited pay a dividend?
PW Medtech Group Limited has a dividend yield of 7.1%.
What does PW Medtech Group Limited do?
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.